Published On:June 6 2008
Story Viewed 2232 Times
IPCA to enter US market
Coimbatore: IPCA Laboratories Ltd has received approval from the US Food and Drugs Administration to manufacture propranolol hydrochloride tablets USP 10 mg, 20 mg, 40 mg, 60 mg and 80 mg for the US market. Total annual market for the tablets in the US was $ 24.1 million.